02:18 , Feb 20, 2015 |  BC Extra  |  Company News

Management tracks

Kymab Ltd. (Cambridge, U.K.) hired Anne Hyland as CFO, effective March 1. Hyland was CFO at BBI Diagnostics Group plc (Cardiff, U.K.) and Vectura Group plc (LSE:VEC). ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC) hired Steven Swanson as...
07:00 , Jun 23, 2014 |  BC Week In Review  |  Financial News

Alere Inc financial update

Alere Inc . (NYSE:ALR), Waltham, Mass.   Business: Diagnostic   Date announced: 2014-06-18   Note: Alere said it no longer plans to pursue an IPO in the U.K. for its BBI Diagnostics Group plc subsidiary,...
07:00 , Jun 23, 2014 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Cubist Pharmaceuticals Inc. (NASDAQ:CBST) gained $3.69 to $72.24 on Friday after FDA approved an NDA for Cubist's Sivextro tedizolid to treat acute bacterial skin and skin structure infections (ABSSSIs) caused by certain susceptible...
00:56 , Jun 19, 2014 |  BC Extra  |  Financial News

Alere pulls IPO plans for subsidiary

Alere Inc. (NYSE:ALR) said it no longer plans to pursue an IPO in the U.K. for its BBI Diagnostics Group plc subsidiary, which develops, manufactures and markets reagents for diagnostic tests and advanced laboratory diagnostic...
07:00 , May 26, 2014 |  BC Week In Review  |  Financial News

BBI Diagnostics Group financial update

The BBI Diagnostics Group plc subsidiary of diagnostic company Alere Inc. (NYSE:ALR, Waltham, Mass.) plans to launch an IPO in June on the London Stock Exchange underwritten by Jefferies; Berenberg Bank; and Investec Bank. BBI...
07:00 , May 26, 2014 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones AB Science S.A. (Euronext:AB) was up €0.29 to €11.32 on Friday after EMA's CHMP reiterated its recommendation against conditional approval of Masiviera masitinib for first-line treatment of non-resectable locally advanced or metastatic pancreatic...
00:56 , May 20, 2014 |  BC Extra  |  Financial News

Alere subsidiary planning June IPO on LSE

The BBI Diagnostics Group plc subsidiary of diagnostic company Alere Inc. (NYSE:ALR) plans to launch an IPO in June on the London Stock Exchange underwritten by Jefferies; Berenberg Bank; and Investec Bank. BBI said it...
07:00 , May 12, 2014 |  BC Week In Review  |  Company News

Alere diagnostic news

Alere announced as part of the ongoing review of its corporate governance policies, the diagnostic company has decided to separate the roles of chairman and CEO. The board of directors unanimously elected Gregg Powers, a...
07:00 , May 5, 2014 |  BC Week In Review  |  Financial News

BBI Diagnostics Group proposes IPO

BBI Diagnostics Group plc , Cardiff, U.K.   Business: Supply/Service   Date announced: 4/29/14   Type: IPO   To be raised: TBD   Shares: TBD   Price: TBD   Note: BBI Diagnostics Group is seeking...
00:43 , Apr 30, 2014 |  BC Extra  |  Financial News

Alere planning U.K. IPO for subsidiary

Around the end of this quarter, diagnostic company Alere Inc. (NYSE:ALR) said it plans to complete an IPO in the U.K. for its newly formed BBI Diagnostics Group plc subsidiary, which develops, manufactures and markets...